134 related articles for article (PubMed ID: 10568818)
1. Modulation of fas-mediated apoptosis in osteosarcoma cell lines.
Hamada T; Komiya S; Yano H; Zenmyo M; Hiraoka K; Inoue A; Morimatsu M
Int J Oncol; 1999 Dec; 15(6):1125-31. PubMed ID: 10568818
[TBL] [Abstract][Full Text] [Related]
2. Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines.
Fellenberg J; Mau H; Scheuerpflug C; Ewerbeck V; Debatin KM
Int J Cancer; 1997 Jul; 72(3):536-42. PubMed ID: 9247301
[TBL] [Abstract][Full Text] [Related]
3. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
Shinohara H; Yagita H; Ikawa Y; Oyaizu N
Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
[TBL] [Abstract][Full Text] [Related]
4. Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines.
Yano H; Fukuda K; Haramaki M; Momosaki S; Ogasawara S; Higaki K; Kojiro M
J Hepatol; 1996 Oct; 25(4):454-64. PubMed ID: 8912144
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
Quirk SM; Porter DA; Huber SC; Cowan RG
Endocrinology; 1998 Dec; 139(12):4860-9. PubMed ID: 9832422
[TBL] [Abstract][Full Text] [Related]
6. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
Kim KM; Lee K; Hong YS; Park HY
Exp Mol Med; 2000 Dec; 32(4):246-54. PubMed ID: 11190279
[TBL] [Abstract][Full Text] [Related]
7. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma sensitizes osteosarcoma cells to Fas-induced apoptosis by up-regulating Fas receptors and caspase-8.
Inaba H; Glibetic M; Buck S; Ravindranath Y; Kaplan J
Pediatr Blood Cancer; 2004 Dec; 43(7):729-36. PubMed ID: 15390286
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 modulates Fas-mediated apoptosis in human renal cell carcinoma cell lines.
Hara I; Hara S; Miyake H; Arakawa S; Kamidono S
Int J Oncol; 2001 Jun; 18(6):1181-5. PubMed ID: 11351249
[TBL] [Abstract][Full Text] [Related]
10. Responsiveness of mouse corpora luteal cells to Fas antigen (CD95)-mediated apoptosis.
Quirk SM; Harman RM; Huber SC; Cowan RG
Biol Reprod; 2000 Jul; 63(1):49-56. PubMed ID: 10859241
[TBL] [Abstract][Full Text] [Related]
11. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
12. Fas aggregation does not correlate with Fas-mediated apoptosis.
Lee Y; Shacter E
J Immunol; 2001 Jul; 167(1):82-9. PubMed ID: 11418635
[TBL] [Abstract][Full Text] [Related]
13. Fas expression and Fas monoclonal antibody-induced apoptosis in a human squamous cell carcinoma cell line, SCC-25.
Seta C; Fujita M; Muraki Y; Fukuda J; Kobayashi S; Haneji T
J Oral Pathol Med; 2000 Jul; 29(6):271-8. PubMed ID: 10890558
[TBL] [Abstract][Full Text] [Related]
14. Fas/APO-1 gene transfer for human malignant glioma.
Weller M; Malipiero U; Rensing-Ehl A; Barr PJ; Fontana A
Cancer Res; 1995 Jul; 55(13):2936-44. PubMed ID: 7540953
[TBL] [Abstract][Full Text] [Related]
15. Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44.
Günthert AR; Sträter J; von Reyher U; Henne C; Joos S; Koretz K; Moldenhauer G; Krammer PH; Möller P
J Cell Biol; 1996 Aug; 134(4):1089-96. PubMed ID: 8769429
[TBL] [Abstract][Full Text] [Related]
16. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis.
von Reyher U; Sträter J; Kittstein W; Gschwendt M; Krammer PH; Möller P
Cancer Res; 1998 Feb; 58(3):526-34. PubMed ID: 9458101
[TBL] [Abstract][Full Text] [Related]
17. Selection for drug resistance results in resistance to Fas-mediated apoptosis.
Landowski TH; Gleason-Guzman MC; Dalton WS
Blood; 1997 Mar; 89(6):1854-61. PubMed ID: 9058704
[TBL] [Abstract][Full Text] [Related]
18. Resistance to Fas-mediated apoptosis in human hepatoma cells.
Natoli G; Ianni A; Costanzo A; De Petrillo G; Ilari I; Chirillo P; Balsano C; Levrero M
Oncogene; 1995 Sep; 11(6):1157-64. PubMed ID: 7566976
[TBL] [Abstract][Full Text] [Related]
19. Soluble Fas/Apo-1 splicing variants and apoptosis.
Cascino I; Papoff G; Eramo A; Ruberti G
Front Biosci; 1996 Jan; 1():d12-8. PubMed ID: 9159204
[TBL] [Abstract][Full Text] [Related]
20. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]